Grey Wolf is a UK and Australian-based drug discovery and development company focused on developing novel immuno-oncology agents. The company was founded in 2017 by experienced industry professionals; Tom McCarthy (Executive Chairman; former..
CTS aims to develop theoretical and applied research and encourages technology transfer mostly supported by spin offs and deep involvement in international R&D projects...